Volume | 1,113,532 |
|
|||||
News | - | ||||||
Day High | 212.00 | Low High |
|||||
Day Low | 208.63 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ResMed Inc | RMD | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
210.97 | 208.63 | 212.00 | 211.73 | 212.38 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
15,780 | 1,113,532 | $ 210.88 | $ 234,824,412 | - | 132.24 - 229.97 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 208,402 | $ 211.73 | USD |
ResMed (RMD) Options Flow Summary
ResMed Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
31.14B | 147.09M | - | 4.22B | 897.56M | 6.10 | 34.70 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ResMed News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RMD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 211.46 | 214.54 | 207.05 | 211.27 | 711,576 | 0.27 | 0.13% |
1 Month | 219.82 | 220.035 | 204.41 | 210.48 | 825,975 | -8.09 | -3.68% |
3 Months | 193.60 | 222.96 | 172.19 | 201.58 | 1,035,678 | 18.13 | 9.36% |
6 Months | 173.96 | 222.96 | 164.1225 | 191.33 | 993,996 | 37.77 | 21.71% |
1 Year | 216.14 | 229.97 | 132.24 | 174.55 | 1,158,383 | -4.41 | -2.04% |
3 Years | 221.50 | 301.34 | 132.24 | 203.53 | 760,385 | -9.77 | -4.41% |
5 Years | 119.28 | 301.34 | 108.85 | 191.90 | 698,030 | 92.45 | 77.51% |
ResMed Description
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting. |